Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Health Technology Assessment (Winchester, England)
|
March 10, 2007
Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
P Tappenden, R Jones, S Paisley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 4, 2007
The cost-effectiveness of bevacizumab in the first-line treatment of metastatic colorectal cancer in England and Wales
P Tappenden, R Jones, S Paisley, et al.
Health Technology Assessment (Winchester, England)
|
October 7, 2009
Varenicline in the management of smoking cessation: a single technology appraisal
D Hind, P Tappenden, J Peters, et al.
Health Technology Assessment (Winchester, England)
|
September 23, 2003
The role of modelling in prioritising and planning clinical trials
J Chilcott, A Brennan, A Booth, et al.
Health Technology Assessment (Winchester, England)
|
April 12, 2012
The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review
P Tappenden, F Campbell, A Rawdin, et al.
Clinical Therapeutics
|
January 5, 2002
A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus
J Chilcott, P Tappenden, M L Jones, et al.
Health Technology Assessment (Winchester, England)
|
October 20, 2006
The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation
A Pandor, S Eggington, S Paisley, et al.
Health Technology Assessment (Winchester, England)
|
June 25, 2004
Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis
P Tappenden, J B Chilcott, S Eggington, et al.
Health Technology Assessment (Winchester, England)
|
May 9, 2008
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation
D Hind, P Tappenden, I Tumur, et al.
Journal of Medical Screening
|
December 25, 2008
Predicting the impact of the screening programme for colorectal cancer in the UK
D M Parkin, P Tappenden, A H Olsen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Health Technology Assessment (Winchester, England)
|
March 10, 2007
Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
P Tappenden, R Jones, S Paisley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 4, 2007
The cost-effectiveness of bevacizumab in the first-line treatment of metastatic colorectal cancer in England and Wales
P Tappenden, R Jones, S Paisley, et al.
Health Technology Assessment (Winchester, England)
|
October 7, 2009
Varenicline in the management of smoking cessation: a single technology appraisal
D Hind, P Tappenden, J Peters, et al.
Health Technology Assessment (Winchester, England)
|
September 23, 2003
The role of modelling in prioritising and planning clinical trials
J Chilcott, A Brennan, A Booth, et al.
Health Technology Assessment (Winchester, England)
|
April 12, 2012
The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review
P Tappenden, F Campbell, A Rawdin, et al.
Clinical Therapeutics
|
January 5, 2002
A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus
J Chilcott, P Tappenden, M L Jones, et al.
Health Technology Assessment (Winchester, England)
|
October 20, 2006
The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation
A Pandor, S Eggington, S Paisley, et al.
Health Technology Assessment (Winchester, England)
|
June 25, 2004
Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis
P Tappenden, J B Chilcott, S Eggington, et al.
Health Technology Assessment (Winchester, England)
|
May 9, 2008
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation
D Hind, P Tappenden, I Tumur, et al.
Journal of Medical Screening
|
December 25, 2008
Predicting the impact of the screening programme for colorectal cancer in the UK
D M Parkin, P Tappenden, A H Olsen, et al.
Page
of 3